The Market Reports

Index

1 Enoxaparin Sodium Market Overview
1.1 Product Overview and Scope of Enoxaparin Sodium
1.2 Enoxaparin Sodium Segment by Type
1.2.1 Global Enoxaparin Sodium Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 20 mg/0.2mL
1.2.3 30 mg/0.3mL
1.2.4 40 mg/0.4mL
1.2.5 60 mg/0.6mL
1.2.6 80 mg/0.8mL
1.2.7 100 mg/1mL
1.2.8 120 mg/0.8mL
1.2.9 150 mg/1mL
1.2.10 300mg/3mL
1.3 Enoxaparin Sodium Segment by Application
1.3.1 Global Enoxaparin Sodium Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Enoxaparin Sodium Market Size Estimates and Forecasts
1.4.1 Global Enoxaparin Sodium Revenue 2016-2027
1.4.2 Global Enoxaparin Sodium Sales 2016-2027
1.4.3 Enoxaparin Sodium Market Size by Region: 2016 Versus 2021 Versus 2027

2 Enoxaparin Sodium Market Competition by Manufacturers
2.1 Global Enoxaparin Sodium Sales Market Share by Manufacturers (2016-2021)
2.2 Global Enoxaparin Sodium Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Enoxaparin Sodium Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Enoxaparin Sodium Manufacturing Sites, Area Served, Product Type
2.5 Enoxaparin Sodium Market Competitive Situation and Trends
2.5.1 Enoxaparin Sodium Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Enoxaparin Sodium Players Market Share by Revenue
2.5.3 Global Enoxaparin Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Enoxaparin Sodium Retrospective Market Scenario by Region
3.1 Global Enoxaparin Sodium Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Enoxaparin Sodium Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Enoxaparin Sodium Market Facts & Figures by Country
3.3.1 North America Enoxaparin Sodium Sales by Country
3.3.2 North America Enoxaparin Sodium Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Enoxaparin Sodium Market Facts & Figures by Country
3.4.1 Europe Enoxaparin Sodium Sales by Country
3.4.2 Europe Enoxaparin Sodium Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Enoxaparin Sodium Market Facts & Figures by Region
3.5.1 Asia Pacific Enoxaparin Sodium Sales by Region
3.5.2 Asia Pacific Enoxaparin Sodium Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Enoxaparin Sodium Market Facts & Figures by Country
3.6.1 Latin America Enoxaparin Sodium Sales by Country
3.6.2 Latin America Enoxaparin Sodium Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Enoxaparin Sodium Market Facts & Figures by Country
3.7.1 Middle East and Africa Enoxaparin Sodium Sales by Country
3.7.2 Middle East and Africa Enoxaparin Sodium Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Enoxaparin Sodium Historic Market Analysis by Type
4.1 Global Enoxaparin Sodium Sales Market Share by Type (2016-2021)
4.2 Global Enoxaparin Sodium Revenue Market Share by Type (2016-2021)
4.3 Global Enoxaparin Sodium Price by Type (2016-2021)

5 Global Enoxaparin Sodium Historic Market Analysis by Application
5.1 Global Enoxaparin Sodium Sales Market Share by Application (2016-2021)
5.2 Global Enoxaparin Sodium Revenue Market Share by Application (2016-2021)
5.3 Global Enoxaparin Sodium Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi Enoxaparin Sodium Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Teva Enoxaparin Sodium Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Techdow (Hepalink)
6.3.1 Techdow (Hepalink) Corporation Information
6.3.2 Techdow (Hepalink) Description and Business Overview
6.3.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
6.3.5 Techdow (Hepalink) Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Fresenius Kabi Enoxaparin Sodium Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Rovi
6.5.1 Rovi Corporation Information
6.5.2 Rovi Description and Business Overview
6.5.3 Rovi Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Rovi Enoxaparin Sodium Product Portfolio
6.5.5 Rovi Recent Developments/Updates
6.6 Amphastar
6.6.1 Amphastar Corporation Information
6.6.2 Amphastar Description and Business Overview
6.6.3 Amphastar Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Amphastar Enoxaparin Sodium Product Portfolio
6.6.5 Amphastar Recent Developments/Updates
6.7 Nanjing King-friend
6.6.1 Nanjing King-friend Corporation Information
6.6.2 Nanjing King-friend Description and Business Overview
6.6.3 Nanjing King-friend Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nanjing King-friend Enoxaparin Sodium Product Portfolio
6.7.5 Nanjing King-friend Recent Developments/Updates
6.8 Sandoz
6.8.1 Sandoz Corporation Information
6.8.2 Sandoz Description and Business Overview
6.8.3 Sandoz Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sandoz Enoxaparin Sodium Product Portfolio
6.8.5 Sandoz Recent Developments/Updates
6.9 Apotex
6.9.1 Apotex Corporation Information
6.9.2 Apotex Description and Business Overview
6.9.3 Apotex Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Apotex Enoxaparin Sodium Product Portfolio
6.9.5 Apotex Recent Developments/Updates
6.10 Hangzhou Jiuyuan Gene Engineering
6.10.1 Hangzhou Jiuyuan Gene Engineering Corporation Information
6.10.2 Hangzhou Jiuyuan Gene Engineering Description and Business Overview
6.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio
6.10.5 Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
6.11 Cipla
6.11.1 Cipla Corporation Information
6.11.2 Cipla Enoxaparin Sodium Description and Business Overview
6.11.3 Cipla Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Cipla Enoxaparin Sodium Product Portfolio
6.11.5 Cipla Recent Developments/Updates
6.12 Taj Pharma
6.12.1 Taj Pharma Corporation Information
6.12.2 Taj Pharma Enoxaparin Sodium Description and Business Overview
6.12.3 Taj Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Taj Pharma Enoxaparin Sodium Product Portfolio
6.12.5 Taj Pharma Recent Developments/Updates
6.13 Chengdu Baiyu Pharmaceutical
6.13.1 Chengdu Baiyu Pharmaceutical Corporation Information
6.13.2 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Description and Business Overview
6.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
6.13.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
6.14 Suzhou Erye Pharmaceutical
6.14.1 Suzhou Erye Pharmaceutical Corporation Information
6.14.2 Suzhou Erye Pharmaceutical Enoxaparin Sodium Description and Business Overview
6.14.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio
6.14.5 Suzhou Erye Pharmaceutical Recent Developments/Updates
6.15 Changzhou Qianhong Bio-pharma
6.15.1 Changzhou Qianhong Bio-pharma Corporation Information
6.15.2 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Description and Business Overview
6.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
6.15.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
6.16 Hebei Changshan Biochemical Pharmaceutical
6.16.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information
6.16.2 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Description and Business Overview
6.16.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio
6.16.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
6.17 Beijing SL Pharmaceutical
6.17.1 Beijing SL Pharmaceutical Corporation Information
6.17.2 Beijing SL Pharmaceutical Enoxaparin Sodium Description and Business Overview
6.17.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
6.17.5 Beijing SL Pharmaceutical Recent Developments/Updates
6.18 Huadong Medicine
6.18.1 Huadong Medicine Corporation Information
6.18.2 Huadong Medicine Enoxaparin Sodium Description and Business Overview
6.18.3 Huadong Medicine Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Huadong Medicine Enoxaparin Sodium Product Portfolio
6.18.5 Huadong Medicine Recent Developments/Updates
6.19 Bharat Serums
6.19.1 Bharat Serums Corporation Information
6.19.2 Bharat Serums Enoxaparin Sodium Description and Business Overview
6.19.3 Bharat Serums Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Bharat Serums Enoxaparin Sodium Product Portfolio
6.19.5 Bharat Serums Recent Developments/Updates
6.20 INTAS
6.20.1 INTAS Corporation Information
6.20.2 INTAS Enoxaparin Sodium Description and Business Overview
6.20.3 INTAS Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.20.4 INTAS Enoxaparin Sodium Product Portfolio
6.20.5 INTAS Recent Developments/Updates
6.21 LUPIN
6.21.1 LUPIN Corporation Information
6.21.2 LUPIN Enoxaparin Sodium Description and Business Overview
6.21.3 LUPIN Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.21.4 LUPIN Enoxaparin Sodium Product Portfolio
6.21.5 LUPIN Recent Developments/Updates
6.22 Troikaa Pharmaceuticals
6.22.1 Troikaa Pharmaceuticals Corporation Information
6.22.2 Troikaa Pharmaceuticals Enoxaparin Sodium Description and Business Overview
6.22.3 Troikaa Pharmaceuticals Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio
6.22.5 Troikaa Pharmaceuticals Recent Developments/Updates
6.23 Aristopharma
6.23.1 Aristopharma Corporation Information
6.23.2 Aristopharma Enoxaparin Sodium Description and Business Overview
6.23.3 Aristopharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Aristopharma Enoxaparin Sodium Product Portfolio
6.23.5 Aristopharma Recent Developments/Updates
6.24 Fosun Pharma
6.24.1 Fosun Pharma Corporation Information
6.24.2 Fosun Pharma Enoxaparin Sodium Description and Business Overview
6.24.3 Fosun Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Fosun Pharma Enoxaparin Sodium Product Portfolio
6.24.5 Fosun Pharma Recent Developments/Updates
6.25 SciencePharma
6.25.1 SciencePharma Corporation Information
6.25.2 SciencePharma Enoxaparin Sodium Description and Business Overview
6.25.3 SciencePharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.25.4 SciencePharma Enoxaparin Sodium Product Portfolio
6.25.5 SciencePharma Recent Developments/Updates
6.26 PISA
6.26.1 PISA Corporation Information
6.26.2 PISA Enoxaparin Sodium Description and Business Overview
6.26.3 PISA Enoxaparin Sodium Sales, Revenue and Gross Margin (2016-2021)
6.26.4 PISA Enoxaparin Sodium Product Portfolio
6.26.5 PISA Recent Developments/Updates

7 Enoxaparin Sodium Manufacturing Cost Analysis
7.1 Enoxaparin Sodium Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Enoxaparin Sodium
7.4 Enoxaparin Sodium Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Enoxaparin Sodium Distributors List
8.3 Enoxaparin Sodium Customers

9 Enoxaparin Sodium Market Dynamics
9.1 Enoxaparin Sodium Industry Trends
9.2 Enoxaparin Sodium Growth Drivers
9.3 Enoxaparin Sodium Market Challenges
9.4 Enoxaparin Sodium Market Restraints

10 Global Market Forecast
10.1 Enoxaparin Sodium Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Enoxaparin Sodium by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Enoxaparin Sodium by Type (2022-2027)
10.2 Enoxaparin Sodium Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Enoxaparin Sodium by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Enoxaparin Sodium by Application (2022-2027)
10.3 Enoxaparin Sodium Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Enoxaparin Sodium by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Enoxaparin Sodium by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Enoxaparin Sodium Sales (M Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Enoxaparin Sodium Sales (M Units) Comparison by Application (2021-2027)
Table 3. Global Enoxaparin Sodium Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Enoxaparin Sodium Covered in This Study
Table 5. Global Enoxaparin Sodium Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Enoxaparin Sodium Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Enoxaparin Sodium Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Enoxaparin Sodium Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Enoxaparin Sodium Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Enoxaparin Sodium Manufacturing Sites and Area Served
Table 11. Manufacturers Enoxaparin Sodium Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Enoxaparin Sodium by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enoxaparin Sodium as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Enoxaparin Sodium Sales by Region (2016-2021) & (M Units)
Table 16. Global Enoxaparin Sodium Sales Market Share by Region (2016-2021)
Table 17. Global Enoxaparin Sodium Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Enoxaparin Sodium Sales by Country (2016-2021) & (M Units)
Table 19. North America Enoxaparin Sodium Sales Market Share by Country (2016-2021)
Table 20. North America Enoxaparin Sodium Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Enoxaparin Sodium Revenue Market Share by Country (2016-2021)
Table 22. Europe Enoxaparin Sodium Sales by Country (2016-2021) & (M Units)
Table 23. Europe Enoxaparin Sodium Sales Market Share by Country (2016-2021)
Table 24. Europe Enoxaparin Sodium Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Enoxaparin Sodium Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Enoxaparin Sodium Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Enoxaparin Sodium Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Enoxaparin Sodium Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Enoxaparin Sodium Revenue Market Share by Region (2016-2021)
Table 30. Latin America Enoxaparin Sodium Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Enoxaparin Sodium Sales Market Share by Country (2016-2021)
Table 32. Latin America Enoxaparin Sodium Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Enoxaparin Sodium Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Enoxaparin Sodium Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Enoxaparin Sodium Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Enoxaparin Sodium Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Enoxaparin Sodium Revenue Market Share by Country (2016-2021)
Table 38. Global Enoxaparin Sodium Sales (M Units) by Type (2016-2021)
Table 39. Global Enoxaparin Sodium Sales Market Share by Type (2016-2021)
Table 40. Global Enoxaparin Sodium Revenue (Million US$) by Type (2016-2021)
Table 41. Global Enoxaparin Sodium Revenue Share by Type (2016-2021)
Table 42. Global Enoxaparin Sodium Price (US$/Unit) by Type (2016-2021)
Table 43. Global Enoxaparin Sodium Sales (M Units) by Application (2016-2021)
Table 44. Global Enoxaparin Sodium Sales Market Share by Application (2016-2021)
Table 45. Global Enoxaparin Sodium Revenue (Million US$) by Application (2016-2021)
Table 46. Global Enoxaparin Sodium Revenue Share by Application (2016-2021)
Table 47. Global Enoxaparin Sodium Price (US$/Unit) by Application (2016-2021)
Table 48. Sanofi Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Sanofi Enoxaparin Sodium Product
Table 52. Sanofi Recent Developments/Updates
Table 53. Teva Corporation Information
Table 54. Teva Description and Business Overview
Table 55. Teva Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Teva Enoxaparin Sodium Product
Table 57. Teva Recent Developments/Updates
Table 58. Techdow (Hepalink) Corporation Information
Table 59. Techdow (Hepalink) Description and Business Overview
Table 60. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Techdow (Hepalink) Enoxaparin Sodium Product
Table 62. Techdow (Hepalink) Recent Developments/Updates
Table 63. Fresenius Kabi Corporation Information
Table 64. Fresenius Kabi Description and Business Overview
Table 65. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Fresenius Kabi Enoxaparin Sodium Product
Table 67. Fresenius Kabi Recent Developments/Updates
Table 68. Rovi Corporation Information
Table 69. Rovi Description and Business Overview
Table 70. Rovi Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Rovi Enoxaparin Sodium Product
Table 72. Rovi Recent Developments/Updates
Table 73. Amphastar Corporation Information
Table 74. Amphastar Description and Business Overview
Table 75. Amphastar Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Amphastar Enoxaparin Sodium Product
Table 77. Amphastar Recent Developments/Updates
Table 78. Nanjing King-friend Corporation Information
Table 79. Nanjing King-friend Description and Business Overview
Table 80. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Nanjing King-friend Enoxaparin Sodium Product
Table 82. Nanjing King-friend Recent Developments/Updates
Table 83. Sandoz Corporation Information
Table 84. Sandoz Description and Business Overview
Table 85. Sandoz Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Sandoz Enoxaparin Sodium Product
Table 87. Sandoz Recent Developments/Updates
Table 88. Apotex Corporation Information
Table 89. Apotex Description and Business Overview
Table 90. Apotex Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Apotex Enoxaparin Sodium Product
Table 92. Apotex Recent Developments/Updates
Table 93. Hangzhou Jiuyuan Gene Engineering Corporation Information
Table 94. Hangzhou Jiuyuan Gene Engineering Description and Business Overview
Table 95. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product
Table 97. Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
Table 98. Cipla Corporation Information
Table 99. Cipla Description and Business Overview
Table 100. Cipla Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Cipla Enoxaparin Sodium Product
Table 102. Cipla Recent Developments/Updates
Table 103. Taj Pharma Corporation Information
Table 104. Taj Pharma Description and Business Overview
Table 105. Taj Pharma Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Taj Pharma Enoxaparin Sodium Product
Table 107. Taj Pharma Recent Developments/Updates
Table 108. Chengdu Baiyu Pharmaceutical Corporation Information
Table 109. Chengdu Baiyu Pharmaceutical Description and Business Overview
Table 110. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product
Table 112. Chengdu Baiyu Pharmaceutical Recent Developments/Updates
Table 113. Suzhou Erye Pharmaceutical Corporation Information
Table 114. Suzhou Erye Pharmaceutical Description and Business Overview
Table 115. Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Suzhou Erye Pharmaceutical Enoxaparin Sodium Product
Table 117. Suzhou Erye Pharmaceutical Recent Developments/Updates
Table 118. Changzhou Qianhong Bio-pharma Corporation Information
Table 119. Changzhou Qianhong Bio-pharma Description and Business Overview
Table 120. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product
Table 122. Changzhou Qianhong Bio-pharma Recent Developments/Updates
Table 123. Hebei Changshan Biochemical Pharmaceutical Corporation Information
Table 124. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 125. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product
Table 127. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
Table 128. Beijing SL Pharmaceutical Corporation Information
Table 129. Beijing SL Pharmaceutical Description and Business Overview
Table 130. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Beijing SL Pharmaceutical Enoxaparin Sodium Product
Table 132. Beijing SL Pharmaceutical Recent Developments/Updates
Table 133. Huadong Medicine Corporation Information
Table 134. Huadong Medicine Description and Business Overview
Table 135. Huadong Medicine Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Huadong Medicine Enoxaparin Sodium Product
Table 137. Huadong Medicine Recent Developments/Updates
Table 138. Bharat Serums Corporation Information
Table 139. Bharat Serums Description and Business Overview
Table 140. Bharat Serums Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Bharat Serums Enoxaparin Sodium Product
Table 142. Bharat Serums Recent Developments/Updates
Table 143. INTAS Corporation Information
Table 144. INTAS Description and Business Overview
Table 145. INTAS Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. INTAS Enoxaparin Sodium Product
Table 147. INTAS Recent Developments/Updates
Table 148. LUPIN Corporation Information
Table 149. LUPIN Description and Business Overview
Table 150. LUPIN Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. LUPIN Enoxaparin Sodium Product
Table 152. LUPIN Recent Developments/Updates
Table 153. Troikaa Pharmaceuticals Corporation Information
Table 154. Troikaa Pharmaceuticals Description and Business Overview
Table 155. Troikaa Pharmaceuticals Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 156. Troikaa Pharmaceuticals Enoxaparin Sodium Product
Table 157. Troikaa Pharmaceuticals Recent Developments/Updates
Table 158. Aristopharma Corporation Information
Table 159. Aristopharma Description and Business Overview
Table 160. Aristopharma Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 161. Aristopharma Enoxaparin Sodium Product
Table 162. Aristopharma Recent Developments/Updates
Table 163. Fosun Pharma Corporation Information
Table 164. Fosun Pharma Description and Business Overview
Table 165. Fosun Pharma Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 166. Fosun Pharma Enoxaparin Sodium Product
Table 167. Fosun Pharma Recent Developments/Updates
Table 168. SciencePharma Corporation Information
Table 169. SciencePharma Description and Business Overview
Table 170. SciencePharma Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 171. SciencePharma Enoxaparin Sodium Product
Table 172. SciencePharma Recent Developments/Updates
Table 173. PISA Corporation Information
Table 174. PISA Description and Business Overview
Table 175. PISA Enoxaparin Sodium Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 176. PISA Enoxaparin Sodium Product
Table 177. PISA Recent Developments/Updates
Table 178. Production Base and Market Concentration Rate of Raw Material
Table 179. Key Suppliers of Raw Materials
Table 180. Enoxaparin Sodium Distributors List
Table 181. Enoxaparin Sodium Customers List
Table 182. Enoxaparin Sodium Market Trends
Table 183. Enoxaparin Sodium Growth Drivers
Table 184. Enoxaparin Sodium Market Challenges
Table 185. Enoxaparin Sodium Market Restraints
Table 186. Global Enoxaparin Sodium Sales Forecast by Type (2022-2027) & (M Units)
Table 187. Global Enoxaparin Sodium Sales Market Share Forecast by Type (2022-2027)
Table 188. Global Enoxaparin Sodium Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 189. Global Enoxaparin Sodium Revenue Market Share Forecast by Type (2022-2027)
Table 190. Global Enoxaparin Sodium Sales Forecast by Application (2022-2027) & (M Units)
Table 191. Global Enoxaparin Sodium Sales Market Share Forecast by Application (2022-2027)
Table 192. Global Enoxaparin Sodium Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 193. Global Enoxaparin Sodium Revenue Market Share Forecast by Application (2022-2027)
Table 194. Global Enoxaparin Sodium Sales Forecast by Region (2022-2027) & (M Units)
Table 195. Global Enoxaparin Sodium Sales Market Share Forecast by Region (2022-2027)
Table 196. Global Enoxaparin Sodium Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 197. Global Enoxaparin Sodium Revenue Market Share Forecast by Region (2022-2027)
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Enoxaparin Sodium
Figure 2. Global Enoxaparin Sodium Market Share by Type in 2020 & 2027
Figure 3. 20 mg/0.2mL Product Picture
Figure 4. 30 mg/0.3mL Product Picture
Figure 5. 40 mg/0.4mL Product Picture
Figure 6. 60 mg/0.6mL Product Picture
Figure 7. 80 mg/0.8mL Product Picture
Figure 8. 100 mg/1mL Product Picture
Figure 9. 120 mg/0.8mL Product Picture
Figure 10. 150 mg/1mL Product Picture
Figure 11. 300mg/3mL Product Picture
Figure 12. Global Enoxaparin Sodium Market Share by Application in 2020 & 2027
Figure 13. Hospital
Figure 14. Clinic
Figure 15. Others
Figure 16. Global Enoxaparin Sodium Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Enoxaparin Sodium Market Size 2016-2027 (US$ Million)
Figure 18. Global Enoxaparin Sodium Sales 2016-2027 (M Units)
Figure 19. Global Enoxaparin Sodium Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. Enoxaparin Sodium Sales Share by Manufacturers in 2020
Figure 21. Global Enoxaparin Sodium Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest Enoxaparin Sodium Players: Market Share by Revenue in 2020
Figure 23. Enoxaparin Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global Enoxaparin Sodium Sales Market Share by Region (2016-2021)
Figure 25. Global Enoxaparin Sodium Sales Market Share by Region in 2020
Figure 26. Global Enoxaparin Sodium Revenue Market Share by Region (2016-2021)
Figure 27. Global Enoxaparin Sodium Revenue Market Share by Region in 2020
Figure 28. United States Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. China Taiwan Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. UAE Enoxaparin Sodium Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Enoxaparin Sodium by Type (2016-2021)
Figure 51. Sales Market Share of Enoxaparin Sodium by Application (2016-2021)
Figure 52. Sales Market Share of Enoxaparin Sodium by Application in 2020
Figure 53. Revenue Share of Enoxaparin Sodium by Application (2016-2021)
Figure 54. Revenue Share of Enoxaparin Sodium by Application in 2020
Figure 55. Manufacturing Cost Structure of Enoxaparin Sodium
Figure 56. Manufacturing Process Analysis of Enoxaparin Sodium
Figure 57. Enoxaparin Sodium Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed